[ Price : $8.95]
FDA expands its medical device Early Alert program to cover all products that may pose significant safety risks.[ Price : $8.95]
CDER director George Tidmarsh urges more compliance with clinical trial reporting requirements through the Clinicaltrials.gov gate...[ Price : $8.95]
AbbVie files an NDA for tavapadon, an investigational once-daily oral therapy for Parkinsons disease.[ Price : $8.95]
FDA grants Essilor a de novo marketing authorization for its Stellest eyeglass lenses, which are designed to both correct vision a...[ Price : $8.95]
FDA approves a Crinetics NDA for Palsonify (paltusotine) for treating adults with acromegaly who have had an inadequate response t...[ Price : $8.95]
FDA sends Novartis Pharmaceuticals an untitled letter citing the companys allegedly false or misleading direct-to-consumer televis...[ Price : $8.95]
HHS secretary Robert F. Kennedy, Jr., says FDA is reviewing safety evidence relating to the medication abortion drug mifepristone.[ Price : $8.95]
FDA says the Risk Evaluation and Management Strategy program that has been in place since 2011 for Sanofis thyroid cancer drug Cap...